Table 4.
The relationship between the GCDFP15 positivity and the tumor related factors
| P-value* | GCDFP-15 Positive | GCDFP-15 Negative | Total | ||
|---|---|---|---|---|---|
| 23 | 27 | 50 | Total | ||
| 0.027 | 9(39.1) | 19(70.4) | 28 | <50 years | Age |
| 14(60.9) | 8(29.6) | 22 | >=50 years | ||
| 0.467 | 13(73.7) | 21(84.0) | 34 | <=5 | Size of lesion |
| 5(26.3) | 4(16.0) | 9 | >5 | ||
| 0.313 | 8(44.4%) | 15(60%) | 23 | Negative | Lymph Vascular Invasion |
| 10(55%) | 10(40%) | 20 | Positive | ||
| 0.431 | 1(8.7) | 0(0.0) | 1 | I | Histological grade |
| 6(26.1) | 6(22.2) | 12 | II | ||
| 16(65.2) | 21(77.8) | 37 | III | ||
| 0.325 | 7(30.4) | 5(18.5) | 12 | II | Nuclear grade |
| 16(69.6) | 22(81.5) | 38 | III | ||
| 0.078 | 9(50) | 19(76) | 28 | Negative | Lymph node involvement |
| 9(50) | 6(24) | 15 | Positive |
*Based on Fisher's exact test